Search Results

1 - 10 of 22 items :

  • "haemophilia" x
  • Internal Medicine x
Clear All
A Case of Acquired Hemophilia A with Maxillary Osteitis

factor VIII hemophilia following influenza vaccination. Eur J Clin Pharmacol. 2010;66:1069-70. 5. Collins P, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood. 2007;109:1870-7. 6. Franchini M, Gandini G, Di Paolantonio T, Mariani G. Acquired hemophilia A: a concise review. Am J Hematol. 2005;80:55-63. 7. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired hemophiliawith

Open access
Implantoprosthetic rehabilitation of a patient with severe form of hemophilia B: a case report

subcommittee of factor VIII and factor IX of the scientific and standarization committee of the International Society on Thrombosis and Haemostasis Thromb Haemost. 2001 85 560 [4] Lehmann-Kopydlowska M, Zawilska K. Dental guidelines in congenital hemophilia A and B. Czas Stomatol. 2010;63(6):345-357. Lehmann-Kopydlowska M Zawilska K. Dental guidelines in congenital hemophilia A and B Czas Stomatol. 2010 63 6 345 357 [5] Bjorkman S, Carlsson M, Berntop E. Pharmacokinetics of factor IX in patients with haemophilia B: Methodological aspects and physiological interpretation

Open access
Progressive arthropathy in the course of immune tolerance induction failure in a child with hemophilia A and FVIII inhibitor – a case report

children with severe haemophilia A: a protocol from the UK Haemophilia Centre Doctors’ Organisation Inhibitor and Paediatric Working Parties. Haemophilia 2017;23:654–59. 28574205 10.1111/hae.13264 Collins P Chalmers E Alamelu J et al First-line immune tolerance induction for children with severe haemophilia A: a protocol from the UK Haemophilia Centre Doctors’ Organisation Inhibitor and Paediatric Working Parties Haemophilia 2017 23 654 59 [2] Ananyeva NM, Lacroix-Esmazes S, Hauser CA. Inhibitors in hemophilia A: mechanisms of inhibitor

Open access
The inhibitors – a challenge for the management of patients with hereditary haemophilia A

induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice . Eur J Haematol. 2012; 88 :371-379. 7. ROCINO A., FRANCHINI M., COPPOLA A. Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX . J Clin Med. 2017; 6 ;pii:E46. 8. ECKHARDT C.L., LOOMANS J.I., VAN VELZEN A.S., PETERS M., MAUSER-BUNSHOTEN E.P., SCHWAAB R., et al. Inhibitor development and mortality in non-severe hemophilia A . J Thromb Haemost. 2015; 13 :1217-1225. 9. FRANCHINI M., LIPPI G

Open access
Diagnostic accuracy of haemophilia early arthropathy detection with ultrasound (HEAD-US): a comparative magnetic resonance imaging (MRI) study

2000 42 205 9 PMID: 11105618 3 Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia 2006; 12: 117-21. 10.1111/j.1365-2516.2006.01268.x Roosendaal G Lafeber FP Pathogenesis of haemophilic arthropathy Haemophilia 2006 12 117 21 10.1111/j.1365-2516.2006.01268.x 4 Manco-Johnson MJ, Abshire TC, Schapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44. 10.1056/NEJMoa067659 Manco

Open access
Multidiciplinary Treatment of a Haemophilic Person with Total Hip Replacement Surgery- A Case Report

References 1. Bossard D, Carrillon Y, Stieltjes N, Larbre J.P., Laurian Y, Molina V, Dirat G. Management of haemophilic arthropathy. Haemophilia. 2008;14(Suppl. 4):11-19. 2. Heijnen L, Dirat G, Chen L, Tulaar A.B.M., Moysisyan L., Nassar N.M.M., Batistella L.B. The role of the physiatrists in haemophilia comprehensive care team in different parts of the world. Haemophilia. 2008;14(Suppl.3):153-161. 3. Battistella LR. Multidisciplinary aspects of rehabilitation in developing countries. In Copmrehensive

Open access
False-negative coagulation factor activity results due to the presence of antiphospholipid antibodies in a case of autoimmune hemolytic anemia

detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia 2007;13:317-322. 10.1111/j.1365-2516.2007.01450.x Sahud MA Pratt KP Zhukov O Qu K Thompson AR. ELISA system for detection of immune responses to FVIII. a study of 246 samples and correlation with the Bethesda assay Haemophilia 2007 13 317 322 [12] Tiede A, Werwitzke S, Scharf RE: Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014;40:803-811. 10.1055/s-0034-1390004 Tiede A Werwitzke S Scharf

Open access
Terapia manualna po alloplastyce stawu kolanowego u pacjenta z artropatią hemofilową w przebiegu hemofilii A – studium przypadku

arthroplasty. Haemophilia 2011;17:999–1004. Viliani T Zambelan G Pandolfi C et al In‐patient rehabilitation in haemophilic subjects with total knee arthroplasty Haemophilia 2011 17 999 1004 [4] Stephensen D, Bladen M, McLaughlin P. Recent advances in musculoskeletal physiotherapy for haemophilia. Ther Adv Hematol 2018;9:227–37. 10.1177/2040620718784834 30181843 Stephensen D Bladen M McLaughlin P Recent advances in musculoskeletal physiotherapy for haemophilia Ther Adv Hematol 2018 9 227 37 [5] Jaworski JM, Zawojski A, Zdziarska J

Open access
Acute Coronary Syndromes in Patients with Hematological Disorders

Invasive Cardiol. 2013;25:E81-E86. 14. Rana MA, Vutukuri NM, Acharya MM, Akkus NI. Acute coronary syndrome and coronary intervention in a patient with type 2M von Willebrand disease. Int J Cardiol. 2014;176:484-485. doi: 10.1016/j.ijcard.2014.06.066. 15. Martin K, Key NS. How I treat patients with inherited bleeding disorders who need anticoagulant therapy. Blood. 2016;128:178-184. doi: 10.1182/blood-2015-12-635094. 16. Zawilska K, Podolak-Dawidziak M. Therapeutic problems in elderly patients with hemophilia. Pol Arch Med Wewn. 2012

Open access
Noninvasive Assessment of Coronary Arteries in Patients with Hematologic Disorders

-Scherrer A. Management of an acute coronary syndrome in a patient with severe haemophilia A. Haemophilia . 2007;13:763-765. 21. Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B. Myocardial Infarction and Other Arterial Occlusions in Hemophilia A Patients. Acta Haematol . 2006;116:120-125. 22. Spiel AO, Gilbert JC, Jilma B. Von Willebrand Factor in Cardiovascular Disease. Focus on Acute Coronary Syndromes. Circulation . 2008;117:1449-1459. 23. Schutgens RE, Tuinenburg A, Roosendaal G, Guyomi SH, Mauser-Bunschoten EP. Treatment of

Open access